Jarrad Rowse, MD
Vascular Surgery · Birmingham, ALNPI 1366881385
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (38.1%), food and beverage and travel and lodging — rather than concentrated in one kind of arrangement. Endologix LLC accounts for 62.2% of it on its own, with 13 other manufacturers making up the rest. 2025 is the largest year on record at $7,704, more than ten times the $259 reported in 2019.
Across 86 payments — averaging $120.26 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Endologix LLC$6K
- W. L. Gore & Associates, Inc.$2K
- Bolton Medical Inc$636
- Medtronic$253
- Cook Medical LLC$207
- Boston Scientific$67
- plus $277 from 8 others
Across 67 payments — averaging $1972.98 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Endologix LLC$87K
- Penumbra, Inc.$45K
What the payments were for
- Consulting fees$3,93838%
- Travel & lodging$2,62025%
- Food & beverage$3,78537%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Endologix LLC | 19 | $6,432 |
| W. L. Gore & Associates, Inc. | 31 | $2,471 |
| Bolton Medical Inc | 10 | $636 |
| Medtronic(2 entities) | 5 | $253 |
| Cook Medical LLC | 8 | $207 |
| Boston Scientific | 2 | $67 |
| Baxter Healthcare | 2 | $51 |
| Kerecis Limited | 2 | $50 |
| Penumbra, Inc. | 1 | $46 |
| Lemaitre Vascular, Inc. | 1 | $45 |
| Bard Peripheral Vascular, Inc. | 2 | $37 |
| Imperative Care, Inc | 1 | $16 |
| Johnson & Johnson | 1 | $16 |
| Janssen Scientific Affairs, LLC | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- Alto Abdominal Stent Graft System$4,809
- AFX2 Bifurcated Endograft System$2,127
- Product in Development$981
- Torus Stent Graft System$385
- ENDOCROSS Device$385
- GORE VIABAHN VBX Balloon Expandable Endo$331
- GORE TAG Conformable Thoracic Endoprosthesis$283
- EXCLUDER Conformable AAA Endoprosthesis with Active Control$143
- Relay Grafts$133
- TREO ABDOMINAL STENT-GRAFT SYSTEM$131
- IN.PACT Admiral$123
- C3 Delivery System$107
How this compares
$10,343 in reported general payments places this provider in the 70th percentile of 61 vascular surgery providers in Alabama.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Oxycodone Hcl | 27 | $123 |
Paid to pharmacies, not to this prescriber.
Other vascular surgery in Birmingham
- Albert PacificoBirmingham$5.1M
- Benjamin PearceBirmingham$37K
- William HolmanBirmingham$25K
- Stephen HeinzmanBirmingham$18K
- Graeme McFarlandBirmingham$10K
- Vernon HorstBirmingham$9K
- James KirklinBirmingham$6K
- Danielle SutzkoBirmingham$5K
- Mark PattersonBirmingham$5K
- Michael GleasonBirmingham$3K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.